Table 1.
Mucosal Vaccines | |
---|---|
Advantages | Limitations |
Easiness of administration | Lack of effective delivery systems |
Less stringent preparations for purity requirements | Lack of safe and effective adjuvants to enhance the immunogenicity |
Simple production and storage | Further development needed (optimal dose, clinical trials, new indications) |
Problems related to needles are excluded | Poor induction of antigen-specific immune responses |
Facilitated process of mass immunization | |
Presumably induction of both systemic and local immune responses | |
Eliminating cases of asymptomatic carriers of the pathogen |